Skip to content

ENTX

Entera Bio Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$3.00
+1.69%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue42.0K181.0K134.0K
Cost of Revenue15.0K42.0K172.0K56.0K165.0K
Gross Profit(15.0K)9.0K(56.0K)(31.0K)
Operating Expenses
R&D Expense8.8M6.0M4.5M4.5M5.8M
SG&A Expense5.6M5.5M5.1M4.4M7.3M
General & Admin Expense5.6M5.5M5.1M
Selling & Marketing Expense
Other Expenses
Total Operating Expenses14.4M11.5M9.6M8.9M13.0M
Cost and Expenses14.4M11.6M9.8M8.9M13.2M
Operating Income (EBIT)(14.4M)(11.5M)(9.6M)(8.9M)(13.1M)
Non-Operating
Interest Income58.0K31.0K83.0K
Interest Expense2.7M
Net Interest Income(2.7M)58.0K31.0K83.0K
Other Non-Op Income/Expense(2.6M)90.0K58.0K80.0K134.0K
Non-Operating Income (excl Interest)(116.0K)(90.0K)(58.0K)(80.0K)(134.0K)
EBT (Pre-Tax Income)(17.0M)(11.4M)(9.5M)(8.9M)(12.9M)
Income Tax Expense14.0K29.0K137.0K
Bottom Line
Net Income(17.0M)(11.4M)(9.5M)(8.9M)(13.1M)
Earnings from Cont. Ops(17.0M)(11.4M)(9.5M)(8.9M)(13.1M)
Earnings from Discont. Ops
Bottom Line Net Income(17.0M)(11.4M)(9.5M)(8.9M)(13.1M)
Per Share
Basic EPS($0.35)($0.25)($0.25)($0.31)($0.45)
Diluted EPS($0.35)($0.25)($0.25)($0.31)($0.45)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding50.5M46.2M37.7M29.0M28.8M
Diluted Shares Outstanding50.5M46.2M37.7M29.0M28.8M
Profitability Metrics
EBITDA(14.3M)(11.4M)(9.5M)(8.8M)(12.9M)
D&A22.0K30.0K46.0K56.0K64.0K
EBIT(14.3M)(11.4M)(9.5M)(8.9M)(12.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026